PharmaBoardroom

Ramez Mohsen – Managing Director, Janssen Egypt, Jordan,…

Ramez Mohsen, managing director at Janssen for Egypt, Jordan, Libya & Sudan, highlights how the company is driving real access to treatments in…

Frédéric Cren – Chairman, CEO & Co-Founder,…

Inventiva is a French clinical-stage biotech company focused on developing oral small molecule epigenetic modulators in therapeutic areas with high…

The Medical Cannabis Investment Landscape

David H. Crean, managing director for Objective Capital Partners, highlights the progress that has been made over the past year in investments in…

Jesús Cristóbal – CEO, Texpol, Spain

Jesús Cristóbal, CEO of Texpol, the market leader for single-use surgical dressings in Spain, describes the company’s beginnings and his role in…

Ashraf Osman – President and CEO, AUG Pharma, Egypt

Ashraf Osman, president and CEO of AUG Pharma, explains how his company has become one of Egypt’s Top 30 pharmaceutical companies in less than four…

Miriam Rodriguez – General Manager, Aspen Pharmacare Iberia

Miriam Rodriguez, general manager of Aspen Pharmacare Iberia, highlights the steps she has taken to set up the affiliate and how her past experiences…

Jean-Jacques Garaud – CEO, Inotrem, France

Inotrem is a French biotech company developing a novel approach to target inflammatory diseases based on the TREM-1 pathway. Its CEO, Dr Jean-Jacques…

Marc Comas – Managing Director, Accord Healthcare Iberia

Marc Comas, managing director of Accord Healthcare Iberia, highlights the footprint of the company as the leading generics and biosimilars player in…

Is CNS the Next Oncology?

Cerecin's Charles Stacey looks at the large unmet medical need in diseases of the central nervous system (CNS), the looming socioeconomic burden that…